Skip to main content
logo
Elevance Health logo
Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
428.26
-0.17 (-0.04%)
At close: Oct 16, 2026, 4:00 PM EDT
428.25
-0.01 (0.00%)
After-hours: Oct 16, 2026, 4:59 PM EDT

Elevance Health Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Premiums & Annuity Revenue
41,27941,02440,69041,79141,27140,88736,24536,80935,41635,69635,13835,25936,58935,86833,64633,72233,07632,78530,76930,395
Total Interest & Dividend Income
704765493625486590527551508465529493416387373371381360352335
Other Revenue
8,4918,3928,5658,2958,0197,4148,6707,7857,7226,4166,9807,0976,6675,9175,9145,8465,1754,9505,4645,092
Total Revenue
50,47450,18149,74850,71149,77648,89145,44245,14543,64642,57742,64742,84943,67242,17239,93339,93938,63238,09536,58535,822
Revenue Growth (YoY)
1.40%2.64%9.48%12.33%14.04%14.83%6.55%5.36%-0.06%0.96%6.80%7.29%13.05%10.70%9.15%11.49%14.12%17.63%14.96%14.97%
Policy Benefits
37,02435,61538,06538,14036,70635,31233,50032,94930,57230,54631,33430,60631,60430,78630,19529,42128,79528,23127,53826,645
Amortization of Goodwill & Intangibles
110112164162147155180122162116217212221235247225166129135136
Selling, General & Administrative
11,03911,79310,75310,65210,29010,28310,5079,6969,8868,7118,69210,1189,1458,2818,1747,9537,3417,2287,0836,844
Total Operating Expenses
48,17347,52048,98248,95447,14345,75044,18742,76740,62039,37340,24340,93640,97039,30238,61637,59936,30235,58834,75633,625
Operating Income
2,3012,6617661,7572,6333,1411,2552,3783,0263,2042,4041,9132,7022,8701,3172,3402,3302,5071,8292,197
Interest Expense
-364-357-367-351-341-344-340-300-280-265-259-259-261-251-233-213-208-201-204-201
EBT Excluding Unusual Items
1,9372,3043991,4062,2922,7979152,0782,7462,9392,1451,6542,4412,6191,0842,1272,1222,3061,6251,996
Merger & Restructuring Charges
---55----268----752----39----202-
Gain (Loss) on Sale of Assets
--------39240-----------
Asset Writedown
---129----41----392--------7-
Legal Settlements
--------666------------
Other Unusual Items
-------------------16-
Pretax Income
1,9372,3042151,4062,2922,7976061,3732,9862,9391,0011,6542,4412,6191,0452,1272,1222,3061,4001,996
Income Tax Expense
483544-331219548613193365685690170354585615168529488527275494
Earnings From Continuing Ops.
1,4541,7605461,1871,7442,1844131,0082,3012,2498311,3001,8562,0048771,5981,6341,7791,1251,502
Minority Interest in Earnings
9412-1-158-1-325-11-3-15-125310127
Net Income
1,4631,7645471,1891,7432,1834181,0162,3002,2468561,2891,8531,9898651,6031,6371,7891,1371,509
Net Income to Common
1,4631,7645471,1891,7432,1834181,0162,3002,2468561,2891,8531,9898651,6031,6371,7891,1371,509
Net Income Growth (YoY)
-16.06%-19.19%30.86%17.03%-24.22%-2.80%-51.17%-21.18%24.12%12.92%-1.04%-19.59%13.20%11.18%-23.92%6.23%-8.70%7.45%106.35%579.73%
Shares Outstanding (Basic)
217220222223225226231232232233236235237238241240241241246243
Shares Outstanding (Diluted)
218220222224226227231233233234236237238240241242243244246246
Shares Change (YoY)
-3.50%-2.99%-4.02%-4.03%-3.26%-2.99%-1.99%-1.44%-1.85%-2.30%-2.24%-2.35%-2.30%-1.92%-1.75%-1.54%-1.62%-1.53%-2.23%-3.23%
EPS (Basic)
6.748.032.475.327.749.641.814.389.919.653.635.487.838.373.596.696.807.414.636.20
EPS (Diluted)
6.718.002.475.327.729.611.814.369.859.593.635.457.798.303.596.626.737.324.636.13
EPS Growth (YoY)
-13.08%-16.75%36.35%22.02%-21.62%0.21%-50.17%-20.00%26.44%15.54%1.22%-17.67%15.75%13.39%-22.57%7.99%-7.17%9.09%111.06%604.60%

Additional Metrics

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Free Cash Flow
1,6264,097-2097751,7878213842,3451241,699-3,2972,2941,6006,168-1,8164,6192,1572,2871,3322,246
Free Cash Flow Per Share
7.4618.59-0.943.467.913.611.6610.060.537.25-13.989.706.7325.73-7.5319.078.869.365.439.13
Dividend Per Share
1.7201.7201.7101.7101.7101.7101.6301.6301.6301.6301.4801.4801.4801.4801.2801.2801.2801.2801.1301.130
Dividend Growth (YoY)
0.58%0.58%4.91%4.91%4.91%4.91%10.13%10.13%10.13%10.13%15.63%15.63%15.63%15.63%13.27%13.27%13.27%13.27%18.95%18.95%
Operating Margin
4.56%5.30%1.54%3.46%5.29%6.42%2.76%5.27%6.93%7.52%5.64%4.46%6.19%6.80%3.30%5.86%6.03%6.58%5.00%6.13%
Profit Margin
2.90%3.52%1.10%2.34%3.50%4.46%0.92%2.25%5.27%5.27%2.01%3.01%4.24%4.72%2.17%4.01%4.24%4.70%3.11%4.21%
Free Cash Flow Margin
3.22%8.16%-0.42%1.53%3.59%1.68%0.84%5.19%0.28%3.99%-7.73%5.35%3.66%14.63%-4.55%11.56%5.58%6.00%3.64%6.27%
EBITDA
2,6673,0151,1722,1443,0133,5141,6532,7073,3613,5352,8282,3393,1353,3321,7902,7912,7232,8652,1892,548
EBITDA Margin
5.28%6.01%2.36%4.23%6.05%7.19%3.64%6.00%7.70%8.30%6.63%5.46%7.18%7.90%4.48%6.99%7.05%7.52%5.98%7.11%
D&A For EBITDA
366354406387380373398329335331424426433462473451393358360351
EBIT
2,3012,6617661,7572,6333,1411,2552,3783,0263,2042,4041,9132,7022,8701,3172,3402,3302,5071,8292,197
EBIT Margin
4.56%5.30%1.54%3.46%5.29%6.42%2.76%5.27%6.93%7.52%5.64%4.46%6.19%6.80%3.30%5.86%6.03%6.58%5.00%6.13%
Effective Tax Rate
24.93%23.61%-15.58%23.91%21.92%31.85%26.58%22.94%23.48%16.98%21.40%23.96%23.48%16.08%24.87%23.00%22.85%19.64%24.75%
Revenue as Reported
50,47450,18149,74750,71149,77648,89145,44245,10643,88642,57742,64742,84943,67242,17239,92939,93938,63238,09536,58135,822
SEC Filings: 10-K · 10-Q